Gopi Shankar

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

Anthony R. Mire‐Sluis, Yu Chen Barrett, Viswanath Devanarayan et al. · Journal of Immunological Methods · 2004 · 609 citations

Vaccination, Biotechnology Products, Bioanalysis +9

Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies

Rafael Ponce, Leslie W. Abad, Lakshmi Amaravadi et al. · Regulatory Toxicology and Pharmacology · 2009 · 264 citations

Allergy, Immunotoxicology, Medicine +10

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Honghui Zhou, Haishan Jang, Roy Fleischmann et al. · The Journal of Clinical Pharmacology · 2007 · 191 citations

Inflammation, Rheumatology, Rheumatoid Disorder +15

Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab

Jacqueline Benson, Clifford Sachs, George Treacy et al. · Nature Biotechnology · 2011 · 140 citations

Inflammation, Cytokine, Autoimmune Disease +10

Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet® biolayer interferometry

Jian Li, Allen Schantz, Maureen Schwegler et al. · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 80 citations

Octet® Biolayer Interferometry, Drug Tolerance, Medicine +11